Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) EBIT (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed EBIT for 16 consecutive years, with -$71.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT fell 1985.79% year-over-year to -$71.6 million, compared with a TTM value of -$84.4 million through Dec 2025, down 400.53%, and an annual FY2025 reading of -$84.4 million, down 400.53% over the prior year.
  • EBIT was -$71.6 million for Q4 2025 at Cross Country Healthcare, down from -$6.0 million in the prior quarter.
  • Across five years, EBIT topped out at $90.6 million in Q1 2022 and bottomed at -$71.6 million in Q4 2025.
  • Average EBIT over 5 years is $21.0 million, with a median of $18.1 million recorded in 2021.
  • The sharpest move saw EBIT skyrocketed 7041.47% in 2021, then crashed 1985.79% in 2025.
  • Year by year, EBIT stood at $76.0 million in 2021, then plummeted by 36.5% to $48.2 million in 2022, then crashed by 72.17% to $13.4 million in 2023, then plummeted by 125.57% to -$3.4 million in 2024, then plummeted by 1985.79% to -$71.6 million in 2025.
  • Business Quant data shows EBIT for CCRN at -$71.6 million in Q4 2025, -$6.0 million in Q3 2025, and -$5.9 million in Q2 2025.